BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6635666)

  • 21. Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents.
    Mandel RJ; Wictorin K; Cenci MA; Björklund A
    Brain Res; 1992 Jun; 583(1-2):207-15. PubMed ID: 1504828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions.
    Wooten GF; Collins RC
    Brain Res; 1983 Mar; 263(2):267-75. PubMed ID: 6839175
    [No Abstract]   [Full Text] [Related]  

  • 23. Dopamine receptor 'supersensitivity' occurring without receptor up-regulation.
    Mileson BE; Lewis MH; Mailman RB
    Brain Res; 1991 Oct; 561(1):1-10. PubMed ID: 1686741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal substantia nigra and adrenal medullary grafts placed contralateral to the nigrostriatal lesion side induce a decrease in turning behavior but not in dopamine receptor density.
    Mendoza-Ramírez JL; Aguilar-Roblero R; Zainos-Rosales A; Drucker-Colín R
    Restor Neurol Neurosci; 1991 Jan; 3(4):177-85. PubMed ID: 21551635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reinnervation of the denervated striatum by substantia nigra transplants: functional consequences as revealed by pharmacological and sensorimotor testing.
    Björklund A; Dunnett SB; Stenevi U; Lewis ME; Iversen SD
    Brain Res; 1980 Oct; 199(2):307-33. PubMed ID: 7417786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.
    Dunnett SB; Björklund A; Stenevi U; Iversen SD
    Brain Res; 1981 Dec; 229(2):457-70. PubMed ID: 6796197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of substantia nigra lesions on forebrain 2-deoxyglucose retention in the rat.
    Sagar SM; Snodgrass SR
    Brain Res; 1980 Mar; 185(2):335-48. PubMed ID: 6101986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity.
    Neve KA; Kozlowski MR; Marshall JF
    Brain Res; 1982 Jul; 244(1):33-44. PubMed ID: 6288182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
    Dravid A; Jaton AL; Enz A; Frei P
    Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 35. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
    Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
    Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
    Baker KA; Sadi D; Hong M; Mendez I
    J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral effects of fetal substantia nigra tissue grafted into the dopamine-denervated striatum: responses to selective D1 and D2 dopamine receptor agonists.
    Becker JB; Ariano MA
    Restor Neurol Neurosci; 1991 Jan; 3(4):187-95. PubMed ID: 21551636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intraventricular substantia nigra allografts as a function of donor age.
    Simonds GR; Freed WJ
    Brain Res; 1990 Oct; 530(1):12-9. PubMed ID: 2271940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved recovery of nigro-striatally hemitransected rats induced by (Nle4, D-Phe7)alpha-MSH: a central effect.
    Zanoli P; Benelli A; Bertolini A
    Neuropeptides; 1988 Apr; 11(3):137-42. PubMed ID: 2838766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.